lysine has been researched along with tranexamic acid in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 11 (28.21) | 18.7374 |
1990's | 11 (28.21) | 18.2507 |
2000's | 8 (20.51) | 29.6817 |
2010's | 7 (17.95) | 24.3611 |
2020's | 2 (5.13) | 2.80 |
Authors | Studies |
---|---|
Christensen, U | 1 |
Cederholm-Williams, SA; Swain, A | 1 |
Takada, A; Takada, Y | 3 |
Lubinus, J; Zimmermann, RE | 1 |
Matsuda, H; Ohashi, H; Takada, A; Takada, Y | 1 |
Markus, G; Priore, RL; Wissler, FC | 1 |
Christensen, U; Mølgaard, L | 1 |
Castellino, FJ; De Serrano, VS | 2 |
Anonick, PK; Gonias, SL; Vasudevan, J | 1 |
Gaffney, PJ; Longstaff, C | 1 |
De Marco, A; Laursen, RA; Llinás, M; Petros, AM | 1 |
Suenson, E; Thorsen, S | 1 |
Aoki, N; Matsuda, M; Sakata, Y; Tateno, K | 1 |
Fless, GM; Hoover-Plow, JL; Miles, LA; Plow, EF; Scanu, AM | 1 |
Rieks, M; Simmet, T; Syrovets, T; Tippler, B | 1 |
Fless, GM; Furbee, J; Meredith, SC; Santiago, JY | 1 |
Royston, D | 1 |
Baker, MS; O'Mullane, MJ | 1 |
Frank, S; Hrzenjak, A; Kostner, GM; Kostner, K; Sattler, W | 1 |
Hoover-Plow, J; Yuen, L | 1 |
Gaubatz, JW; Ghazzaly, KG; Guevara, J; Hoffman, AS; Hoogeveen, RC; Koschinsky, ML; Morrisett, JD; Pownall, HJ | 1 |
Austin, CA; Lakey, JH; Leontiou, C | 1 |
Bacsik, J; Brustowicz, RM; Sethna, NF; Shapiro, F; Sullivan, LJ; Zurakowski, D | 1 |
Dietzel, C; Filipescu, D; Fontes, ML; Hillel, Z; Hoeft, A; Juneja, R; Levin, J; Mangano, DT; Miao, Y; Ott, E; Titov, T; Tudor, IC; Vuylsteke, A | 1 |
Stief, TW | 1 |
McMurdy, N; Trudell, J | 1 |
Arellano, R; Blajchman, MA; Bussières, JS; Clinch, J; Côté, D; Duke, PC; Fergusson, DA; Fremes, S; Hébert, PC; Karski, J; MacAdams, C; Martineau, R; Mazer, CD; Murkin, JM; Pretorius, R; Robblee, JA; Rodger, M; Teoh, K; Wells, G | 1 |
Acsády, G; Selmeci, L; Seres, L; Soós, P; Székely, M | 1 |
Longstaff, C; Silva, MM; Thelwell, C; Williams, SC | 1 |
Brunskill, SJ; Doree, C; Estcourt, LJ; Murphy, MF; Stanworth, S; Trivella, M; Wardrop, D | 1 |
Beck, A; Breau, RH; Buenaventura, C; Cagiannos, I; Cowan, J; Fergusson, DA; Knoll, G; Kokolo, MB; Momoli, F; Morash, C; Niznick, N; Punjani, N; Ruzicka, M; Schachkina, S; Tinmouth, A; Xie, HY | 1 |
Brunskill, SJ; Desborough, M; Doree, C; Estcourt, LJ; Hopewell, S; Murphy, MF; Stanworth, SJ | 1 |
Byun, SY; Chae, JB; Na, JI; Park, KC | 1 |
Breau, RH; Cagiannos, I; Cnossen, S; Fergusson, DA; Fergusson, NA; Hutton, B; Lavallée, LT; Montroy, J; Morash, C | 1 |
Breau, RH; Cagiannos, I; Fergusson, DA; Flaman, A; Hutton, B; Lavallée, LT; Montroy, J; Morash, C; Tinmouth, A | 1 |
Bayter, JE; Cala, L; Cardenas-Camarena, L; Domínguez-Millan, R; Duran, H; Hoyos, AE; Lopez, A; Mogollon, IR; Perez, M; Talleri, G | 1 |
7 review(s) available for lysine and tranexamic acid
Article | Year |
---|---|
[The enzymatic linkage of fibrinogenesis and fibrinolysis (author's transl)].
Topics: Aminocaproates; Animals; Avian Sarcoma Viruses; Cell Transformation, Neoplastic; Dexamethasone; Factor XII; Fibrin; Fibrinolysin; Fibrinolysis; Hemostasis; Humans; L Cells; Lysine; Mice; Peptide Hydrolases; Plasminogen; Plasminogen Activators; Receptors, Cell Surface; Simian virus 40; Streptokinase; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 1978 |
Aprotinin versus lysine analogues: the debate continues.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Hemostasis, Surgical; Hemostatics; Humans; Lysine; Tranexamic Acid | 1998 |
Current antifibrinolytic therapy for coronary artery revascularization.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Coronary Artery Bypass; Humans; Lysine; Patient Selection; Postoperative Hemorrhage; Risk Factors; Safety Management; Serine Proteinase Inhibitors; Tranexamic Acid; Treatment Outcome | 2008 |
Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Erythrocyte Transfusion; Hematologic Diseases; Hemorrhage; Humans; Lysine; Platelet Transfusion; Thrombocytopenia; Tranexamic Acid | 2013 |
The effects of lysine analogs during pelvic surgery: a systematic review and meta-analysis.
Topics: Aminocaproic Acid; Blood Loss, Surgical; Blood Transfusion; Gynecologic Surgical Procedures; Hemorrhage; Humans; Lysine; Randomized Controlled Trials as Topic; Risk; Surgical Procedures, Operative; Thrombosis; Tranexamic Acid; Treatment Outcome; Urologic Surgical Procedures, Male | 2014 |
Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Erythrocyte Transfusion; Hematologic Diseases; Hemorrhage; Humans; Lysine; Platelet Transfusion; Thrombocytopenia; Thromboembolism; Tranexamic Acid | 2016 |
The Safety and Efficacy of Lysine Analogues in Cancer Patients: A Systematic Review and Meta-Analysis.
Topics: Adult; Aminocaproic Acid; Blood Loss, Surgical; Blood Transfusion; Erythrocyte Transfusion; Humans; Lysine; Neoplasms; Patient Safety; Platelet Transfusion; Randomized Controlled Trials as Topic; Tranexamic Acid; Treatment Outcome; Venous Thrombosis | 2017 |
3 trial(s) available for lysine and tranexamic acid
Article | Year |
---|---|
Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery.
Topics: Adolescent; Antifibrinolytic Agents; Binding Sites; Blood Coagulation Tests; Blood Loss, Surgical; Child; Female; Fibrinolysin; Humans; Lysine; Male; Orthopedic Procedures; Plasminogen; Platelet Count; Scoliosis; Tranexamic Acid | 2005 |
A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Topics: Aged; Aged, 80 and over; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Blood Transfusion; Cardiac Surgical Procedures; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Length of Stay; Lysine; Male; Middle Aged; Postoperative Hemorrhage; Tranexamic Acid; Treatment Outcome | 2008 |
Use of Tranexamic Acid in Liposculpture: A Double-Blind, Multicenter, Randomized Clinical Trial.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Double-Blind Method; Female; Hemoglobins; Humans; Lysine; Male; Postoperative Hemorrhage; Tranexamic Acid | 2022 |
29 other study(ies) available for lysine and tranexamic acid
Article | Year |
---|---|
Allosteric effects of some antifibrinolytic amino acids on the catalytic activity of human plasmin.
Topics: Allosteric Regulation; Allosteric Site; Aminocaproic Acid; Antifibrinolytic Agents; Binding Sites; Catalysis; Enzyme Activation; Fibrinolysin; Humans; Kinetics; Lysine; Mathematics; Tranexamic Acid | 1978 |
The effect of fibrinogen degradation products and some lysine analogues on the dissociation of plasmin(ogen)-fibrin complexes.
Topics: Aminocaproic Acid; Animals; Cattle; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Fibrinolysis; Humans; Lysine; Plasminogen; Protein Binding; Tranexamic Acid | 1979 |
Influence of dextran sulfate and tranexamic acid on the activation of plasminogen by urokinase.
Topics: alpha-2-Antiplasmin; Animals; Binding Sites; Blood Coagulation; Cattle; Cyclohexanecarboxylic Acids; Dextrans; Endopeptidases; Factor XII; Fibrinolysin; Fibrinolysis; Humans; Lysine; Plasminogen Activators; Serum Globulins; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 1979 |
Effects of tranexamic acid, cis-AMCHA, and 6-aminohexanoic acid on the activation rate of plasminogen by urokinase in the presence of clot.
Topics: Aminocaproates; Aminocaproic Acid; Animals; Antifibrinolytic Agents; Blood Coagulation; Cattle; Cyclohexanecarboxylic Acids; Endopeptidases; Humans; Isomerism; Lysine; Oligopeptides; Plasminogen; Thrombin; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 1979 |
The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation.
Topics: Aminocaproates; Cyclohexanecarboxylic Acids; Glutamates; Humans; Kinetics; Lysine; Plasminogen; Protein Binding; Protein Conformation; Tranexamic Acid | 1979 |
Positive co-operative binding at two weak lysine-binding sites governs the Glu-plasminogen conformational change.
Topics: Aminocaproic Acid; Binding Sites; Fluorescence Polarization; Humans; Kinetics; Lysine; Peptide Fragments; Plasminogen; Protein Conformation; Tranexamic Acid | 1992 |
The cationic locus on the recombinant kringle 2 domain of tissue-type plasminogen activator that stabilizes its interaction with omega-amino acids.
Topics: Amino Acid Sequence; Amino Acids; Aminocaproic Acid; Base Sequence; Binding Sites; Cations; DNA; Enzyme Stability; Escherichia coli; Lysine; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Peptide Fragments; Plasmids; Recombinant Proteins; Tissue Plasminogen Activator; Tranexamic Acid | 1992 |
Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
Topics: alpha-Macroglobulins; Amidohydrolases; Aminocaproic Acid; Binding Sites; Binding, Competitive; Blood Coagulation; Fibrinolysin; Fibrinolysis; Humans; Kinetics; Lysine; Peptide Fragments; Serum Globulins; Tranexamic Acid | 1992 |
Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor.
Topics: alpha-Macroglobulins; Aminocaproic Acid; Binding Sites; Chymotrypsin; Fibrinolysin; Humans; Kinetics; Lysine; Models, Biological; Structure-Activity Relationship; Thermodynamics; Tranexamic Acid | 1991 |
Inhibition by tranexamic acid of the conversion of single-chain tissue plasminogen activator to its two chain form by plasmin: the presence on tissue plasminogen activator of a site to bind with lysine binding sites of plasmin.
Topics: Animals; Binding Sites; Cyclohexanecarboxylic Acids; Electrophoresis, Polyacrylamide Gel; Fibrinolysin; Humans; Lysine; Mice; Peptide Fragments; Protein Binding; Tissue Plasminogen Activator; Tranexamic Acid | 1989 |
Analysis of ligand-binding to the kringle 4 fragment from human plasminogen.
Topics: Aminocaproates; Benzylamines; Binding Sites; Humans; Ligands; Lysine; Magnetic Resonance Spectroscopy; Peptide Fragments; Plasminogen; Structure-Activity Relationship; Tranexamic Acid | 1987 |
Enzymatic properties of plasmins converted from acid-treated and native Glu- and Lys-plasminogens by urokinase.
Topics: Fibrinolysin; Glutamates; Humans; Hydrochloric Acid; Hydrolysis; Lysine; Oligopeptides; Plasminogen; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 1981 |
Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
Topics: alpha-2-Antiplasmin; Binding Sites; Electrophoresis, Polyacrylamide Gel; Fibrin; Fibrinolysin; Glutamates; Humans; Lysine; Peptide Fragments; Plasminogen; Protein Binding; Tranexamic Acid | 1981 |
Fibrinolytic states in a patient with congenital deficiency of alpha 2-plasmin inhibitor.
Topics: alpha-2-Antiplasmin; Antigens; Chemical Phenomena; Chemistry; Fibrin; Fibrinogen; Fibrinolysis; Glutamates; Humans; Lysine; Plasminogen; Time Factors; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 1980 |
Comparison of the lysine binding functions of lipoprotein(a) and plasminogen.
Topics: Acetylation; Amino Acid Sequence; Aminocaproic Acid; Binding Sites; Humans; Hydrogen-Ion Concentration; Iodine Radioisotopes; Kringles; Lipoprotein(a); Lysine; Molecular Sequence Data; Plasminogen; Sepharose; Sequence Homology; Structure-Activity Relationship; Tranexamic Acid | 1993 |
Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with omega-amino acid ligands.
Topics: Amino Acid Sequence; Amino Acids; Aminocaproic Acid; Anions; Base Sequence; Binding Sites; Escherichia coli; Lysine; Magnetic Resonance Spectroscopy; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Peptide Fragments; Recombinant Proteins; Thermodynamics; Tissue Plasminogen Activator; Tranexamic Acid; X-Ray Diffraction | 1993 |
Plasmin is a potent and specific chemoattractant for human peripheral monocytes acting via a cyclic guanosine monophosphate-dependent pathway.
Topics: Alkaloids; Aminoquinolines; Benzophenanthridines; Binding Sites; Carbazoles; Chemotactic Factors; Chemotaxis; Cyclic GMP; Enzyme Inhibitors; Fibrinolysin; Glyceryl Ethers; Guanylate Cyclase; Humans; Indoles; Lysine; Male; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Organ Specificity; Pertussis Toxin; Phenanthridines; Plasminogen; Protein Kinase C; Signal Transduction; Thionucleotides; Tranexamic Acid; Urokinase-Type Plasminogen Activator; Virulence Factors, Bordetella | 1997 |
Specificity of ligand-induced conformational change of lipoprotein(a).
Topics: Aminocaproic Acid; Glutamic Acid; Ligands; Lipoprotein(a); Lysine; Models, Chemical; Molecular Weight; Osmolar Concentration; Particle Size; Proline; Protein Conformation; Protein Denaturation; Salts; Tranexamic Acid; Ultracentrifugation | 1997 |
Loss of cell viability dramatically elevates cell surface plasminogen binding and activation.
Topics: Amino Acid Chloromethyl Ketones; Apoptosis; Carboxypeptidase B; Carboxypeptidases; Cell Death; Cell Survival; Cycloheximide; Enzyme Activation; Flow Cytometry; Humans; Kinetics; Lysine; Monocytes; Plasminogen; Plasminogen Activator Inhibitor 2; Plasminogen Inactivators; Protein Synthesis Inhibitors; Tranexamic Acid; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1998 |
Effect of tranexamic acid and delta-aminovaleric acid on lipoprotein(a) metabolism in transgenic mice.
Topics: Amino Acids; Amino Acids, Neutral; Animals; Apolipoproteins A; Cell Line; Half-Life; Lipoprotein(a); Lysine; Mice; Mice, Transgenic; Tranexamic Acid; Transfection | 1999 |
Plasminogen binding is increased with adipocyte differentiation.
Topics: 3T3 Cells; Adipocytes; Aminocaproic Acid; Animals; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Ligands; Lysine; Mice; Mice, Knockout; Plasminogen; Protein Binding; Stromal Cells; Tranexamic Acid | 2001 |
Isolation, quantitation, and characterization of a stable complex formed by Lp[a] binding to triglyceride-rich lipoproteins.
Topics: Aminocaproic Acid; Apolipoproteins A; Arginine; Chromatography, Gel; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Humans; Hypertriglyceridemia; Immunoblotting; Lipoprotein(a); Lysine; Macromolecular Substances; Molecular Weight; Plasmapheresis; Proline; Protein Binding; Tranexamic Acid; Triglycerides; Ultracentrifugation | 2001 |
Mutation E522K in human DNA topoisomerase IIbeta confers resistance to methyl N-(4'-(9-acridinylamino)-phenyl)carbamate hydrochloride and methyl N-(4'-(9-acridinylamino)-3-methoxy-phenyl) methane sulfonamide but hypersensitivity to etoposide.
Topics: Amino Acid Sequence; Amsacrine; Antineoplastic Agents; DNA; DNA Topoisomerases, Type II; Enzyme Stability; Etoposide; Glutamic Acid; Humans; Lysine; Models, Molecular; Mutation; Topoisomerase II Inhibitors; Tranexamic Acid | 2004 |
Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery.
Topics: Aged; Aminocaproates; Antifibrinolytic Agents; Aprotinin; Cardiopulmonary Bypass; Coronary Artery Bypass; Female; Follow-Up Studies; Hemostatics; Humans; Logistic Models; Lysine; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk; Serine Proteinase Inhibitors; Survival Analysis; Tranexamic Acid | 2007 |
In vitro simulation of thrombolysis inhibition.
Topics: Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Humans; Lysine; Tranexamic Acid | 2008 |
Assay of oxidized fibrinogen reactivity (OFR) as a biomarker of oxidative stress in human plasma: the role of lysine analogs.
Topics: Adult; Aged; Aged, 80 and over; Aminocaproates; Apoprotein(a); Biomarkers; Female; Fibrinogen; Humans; Kinetics; Lysine; Male; Middle Aged; Oxidative Stress; Peripheral Vascular Diseases; Tranexamic Acid | 2010 |
Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator.
Topics: Binding Sites; Carboxypeptidase B; Fibrin; Fibrinolysin; Fibrinolysis; Humans; Kinetics; Kringles; Lysine; Plasminogen; Protein Binding; Protein Structure, Tertiary; Tissue Plasminogen Activator; Tranexamic Acid; Urokinase-Type Plasminogen Activator | 2012 |
Significant improvement in crow's feet after treatment with Jet-M and a mixed solution of copper-GHK, oligo-hyaluronic acid, rhodiolar extract, tranexamic acid, and β-glucan (GHR formulation).
Topics: beta-Glucans; Collagen; Cosmetics; Face; Humans; Hyaluronic Acid; Lysine; Male; Middle Aged; Oligopeptides; Organometallic Compounds; Rhodiola; Skin Aging; Tranexamic Acid | 2016 |
Lysine analogue use during cancer surgery: a survey from a Canadian tertiary care centre.
Topics: Aminocaproic Acid; Blood Loss, Surgical; Humans; Lysine; Neoplasms; Ontario; Surveys and Questionnaires; Tertiary Care Centers; Tranexamic Acid | 2020 |